The Waiting Game: Patenting Embryonic Stem Cells in Canada
24 Pages Posted: 26 Apr 2007
Date Written: April 11, 2007
The main focus of this paper is the patentability of human embryonic stem cells ("hESC") in Canada. Its vast therapeutic and economic potential notwithstanding, Canada is yet to grant a patent on products of hESCs research. This paper, therefore, discusses the embryonic stem cell patent regime globally, in Europe and the U.S with a view to making recommendations on the best approach for dealing with embryonic stem cell patents in Canada.
Keywords: Embryonic stem cells, patents, patents laws and policies
JEL Classification: O3, 031, 034.
Suggested Citation: Suggested Citation